Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Breast J

Retrieve available abstracts of 157 articles:
HTML format
Text format



Single Articles


    May 2018
  1. MELNOV S, Murphy P, Foley T, Nadyrov E, et al
    Somatic hematopoietic TP53 mosaicism in women with breast cancer exposed to ionizing radiation.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13056.
    PubMed     Text format    


  2. CAUGHRAN J, Braun TM, Breslin TM, Smith DR, et al
    The Effect of the 2009 USPSTF breast cancer screening recommendations on breast cancer in Michigan: A longitudinal study.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13034.
    PubMed     Text format     Abstract available


  3. MANSOORI Y, Tabei MB, Askari A, Izadi P, et al
    Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13067.
    PubMed     Text format     Abstract available


  4. BALAGAMWALA EH, Manyam BV, Leyrer CM, Karthik N, et al
    Most patients are eligible for an alternative to conventional whole breast irradiation for early-stage breast cancer: A National Cancer Database Analysis.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13051.
    PubMed     Text format     Abstract available


  5. MARIANI M, George K
    Neuropsychological and self-reporting outcomes following rehabilitation of cognitive dysfunction in survivors of breast cancer: A pilot study involving survivor-partner dyads.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13060.
    PubMed     Text format    


  6. BELAID I, Fatma LB, Ezzairi F, Hochlaf M, et al
    Trends and current challenges of breast cancer in Tunisia: a retrospective study of 1262 cases with survival analysis.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13062.
    PubMed     Text format    


  7. WHITE MC, Soman A, Weinberg CR, Rodriguez JL, et al
    Factors associated with breast MRI use among women with a family history of breast cancer.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13063.
    PubMed     Text format     Abstract available


  8. KODAGANUR S, Paga U, Ram A, Krishna A, et al
    Feasibility, safety, and clinical outcomes following latissimus dorsi flap reconstruction in breast cancer- an Institutional study.
    Breast J. 2018 May 8. doi: 10.1111/tbj.13059.
    PubMed     Text format    


    April 2018
  9. MURATA T, Jinno H, Takahashi M, Shimoda M, et al
    Clinicopathologic features of hormone-receptor-positive breast cancer patients with late recurrence.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13033.
    PubMed     Text format     Abstract available


  10. LARSON KE, Grobmyer SR, Valente SA
    Evaluation of recurrence patterns and survival in modern series of young women with breast cancer.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13041.
    PubMed     Text format     Abstract available


  11. JIANG Z, Yang Y, Li S, Pan Z, et al
    A case of tonsillar metastasis from breast cancer and literature review.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13045.
    PubMed     Text format    


  12. KAIDAR-PERSON O, Marks LB, Jones EL
    Pentoxifylline and vitamin E for treatment or prevention of radiation-induced fibrosis in patients with breast cancer.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13044.
    PubMed     Text format     Abstract available


  13. SCHNAPPER G, Marotti L, Casella D, Mano MP, et al
    Data managers: A survey of the European Society of Breast Cancer Specialists in certified multi-disciplinary breast centers.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13043.
    PubMed     Text format     Abstract available


    March 2018
  14. YOON HJ, Kim Y, Chung J, Kim BS, et al
    Predicting neo-adjuvant chemotherapy response and progression-free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F-18 FDG PET/CT and diffusion-weighted MR imaging.
    Breast J. 2018 Mar 30. doi: 10.1111/tbj.13032.
    PubMed     Text format     Abstract available


  15. KIM R, Kawai A, Wakisaka M, Funaoka Y, et al
    Outcomes of outpatient breast cancer surgery at a private breast clinic.
    Breast J. 2018 Mar 14. doi: 10.1111/tbj.13012.
    PubMed     Text format     Abstract available


  16. KEIM-MALPASS J, Doede A, Camacho F, Kennedy C, et al
    Impact of patient health literacy on surgical treatment of breast cancer.
    Breast J. 2018 Mar 14. doi: 10.1111/tbj.13011.
    PubMed     Text format     Abstract available


  17. CHO E, Wu Q, Rubinstein L, Linden H, et al
    Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancer.
    Breast J. 2018 Mar 13. doi: 10.1111/tbj.13013.
    PubMed     Text format     Abstract available


  18. HANLEY BP, Walsh SM, O'Leary DP, MacNally SP, et al
    The significance of receptor status discordance between breast cancer primary and brain metastasis.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13028.
    PubMed     Text format    


  19. DIALANI V, Westra C, Venkataraman S, Fein-Zachary V, et al
    Indications for biopsy of imaging-detected intramammary and axillary lymph nodes in the absence of concurrent breast cancer.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13009.
    PubMed     Text format     Abstract available


  20. VIEIRA RADC, Silveira SFDS, Silva DRD, Tramonte MS, et al
    Knowledge and attitudes about breast cancer care in female inmates in Sao Paulo State/Brazil.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13025.
    PubMed     Text format    


  21. BARCO I, Fraile M, Vidal M, Cambra MJ, et al
    Tamoxifen induced radiation recall dermatitis in a breast cancer patient.
    Breast J. 2018 Mar 8. doi: 10.1111/tbj.13014.
    PubMed     Text format    


  22. O'SHEA E, O'Reilly S, Smiddy P
    Rare imaging appearance of skeletal metastases in a 61-year-old breast cancer patient.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13019.
    PubMed     Text format    


  23. CLIFTON K, Barnett C, Martinez A, Karuturi M, et al
    Severe hyponatremia following cyclophosphamide infusion in breast cancer patients.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13026.
    PubMed     Text format    


  24. KAMAL M, Nafie EHO, Elsers S, Alanwar S, et al
    Ethnicity influences breast cancer stem cells' drug resistance.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13021.
    PubMed     Text format    


  25. VOHRA NA, Brinkley J, Kachare S, Muzaffar M, et al
    Primary tumor resection in metastatic breast cancer: A propensity-matched analysis, 1988-2011 SEER data base.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13005.
    PubMed     Text format     Abstract available


  26. TOZBIKIAN GH, Zynger DL
    HER2 equivocal breast cancer that is positive by alternative probe HER2 FISH are classified as HER2 negative by Oncotype DX.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13004.
    PubMed     Text format     Abstract available


  27. SMITH IORFIDO SM, Makariou E
    Empyema necessitans mimicking inflammatory breast cancer-An unusual case of breast edema.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13015.
    PubMed     Text format    


  28. YADAV S, Jinna S, Pereira-Rodrigues O, Reeves A, et al
    Impact of preoperative BRCA1/2 testing on surgical decision making in patients with newly diagnosed breast cancer.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13007.
    PubMed     Text format     Abstract available


  29. UNKART JT, Proudfoot J, Wallace AM
    Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer.
    Breast J. 2018 Mar 2. doi: 10.1111/tbj.13002.
    PubMed     Text format     Abstract available


    February 2018
  30. NOWIKIEWICZ T, Zegarski W, Pagacz K, Nowacki M, et al
    Does the presence of sentinel lymph node macrometastases in breast cancer patients require axillary lymph node dissection?-Single-center analysis.
    Breast J. 2018 Feb 24. doi: 10.1111/tbj.12997.
    PubMed     Text format     Abstract available


  31. CAMPBELL A, Heydarian R, Ochoa C, Dwivedi AK, et al
    Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
    Breast J. 2018 Feb 14. doi: 10.1111/tbj.12951.
    PubMed     Text format     Abstract available


  32. SWINTELSKI C, Plaza M
    Successful cryoablation of breast cancer.
    Breast J. 2018 Feb 7. doi: 10.1111/tbj.12996.
    PubMed     Text format     Abstract available


    January 2018
  33. WEINER A, D'Andrea GM
    Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer.
    Breast J. 2018 Jan 22. doi: 10.1111/tbj.12972.
    PubMed     Text format     Abstract available


  34. BARROU J, Tallet A, Cohen M, Bannier M, et al
    Contribution of intraoperative radiotherapy (IORT) for therapeutic de-escalation in early breast cancer: Report of a single institution's experience.
    Breast J. 2018 Jan 22. doi: 10.1111/tbj.12993.
    PubMed     Text format     Abstract available


  35. COOPEY SB, Acar A, Griffin M, Cintolo-Gonzalez J, et al
    The impact of patient age on breast cancer risk prediction models.
    Breast J. 2018 Jan 8. doi: 10.1111/tbj.12976.
    PubMed     Text format     Abstract available


    December 2017
  36. DECOSTER L, Fontaine C, Vanacker L, Schallier D, et al
    Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12990.
    PubMed     Text format    


  37. GARG M, Prabhakar N, Singla V, Singh T, et al
    Breast cancer in a patient with neurofibromatosis type 1.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12987.
    PubMed     Text format    


  38. FONSECA V, Brito M
    Starting hormone therapy immediately after histological diagnosis of breast cancer.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12995.
    PubMed     Text format    


  39. MERCKEL LG, Verburg E, van der Velden BHM, Loo CE, et al
    Eligibility of patients for minimally invasive breast cancer therapy based on MRI analysis of tumor proximity to skin and pectoral muscle.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12984.
    PubMed     Text format     Abstract available


  40. MARTIN-ROMANO P, Baraibar I, Espinos J, Legaspi J, et al
    Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12975.
    PubMed     Text format     Abstract available


  41. HWANG E, Yap ML, Boxer MM, Chong S, et al
    Variations in breast cancer histology and treatment patterns between the major ethnic groups of South West Sydney.
    Breast J. 2017 Dec 19. doi: 10.1111/tbj.12973.
    PubMed     Text format     Abstract available


  42. PASRICHA S, Gupta G, Garg R, Sharma A, et al
    Impact of 2013 ASCO/CAP HER2 reporting guidelines in breast cancer: An assessment study from Indian oncology centre that primarily performs HER2 IHC testing with special emphasis on IHC equivocal category.
    Breast J. 2017 Dec 18. doi: 10.1111/tbj.12981.
    PubMed     Text format     Abstract available


  43. KAIDAR-PERSON O, Deal AM, Anders CK, Ewend MG, et al
    The incidence and predictive factors for leptomeningeal spread after stereotactic radiation for breast cancer brain metastases.
    Breast J. 2017 Dec 18. doi: 10.1111/tbj.12919.
    PubMed     Text format    


  44. KUMAR RV, Bhasker S
    A peek into epidemiology, screening, management of breast cancer in developing countries: Experience from two regional cancer centers in India.
    Breast J. 2017 Dec 5. doi: 10.1111/tbj.12965.
    PubMed     Text format    


  45. BAYO J, Avino V, Toscano F, Jimenez F, et al
    Toxicity of docetaxel, carboplatin, and trastuzumab combination as adjuvant or neo-adjuvant treatment for Her2 positive breast cancer patients and impact of colony-stimulating factor prophylaxis.
    Breast J. 2017 Dec 5. doi: 10.1111/tbj.12927.
    PubMed     Text format     Abstract available


    November 2017
  46. LI T, Tang L, Gandomkar Z, Heard R, et al
    Mammographic density and other risk factors for breast cancer among women in China.
    Breast J. 2017 Nov 29. doi: 10.1111/tbj.12967.
    PubMed     Text format    


  47. WEINBERG MS, Shachar SS, Muss HB, Deal AM, et al
    Beyond sarcopenia: Characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population.
    Breast J. 2017 Nov 15. doi: 10.1111/tbj.12952.
    PubMed     Text format     Abstract available


  48. PASSHAK M, Shachar SS, Bar-Sela G, Fried G, et al
    Breast cancer in young women aged 35 and under: Patterns of care and outcome.
    Breast J. 2017 Nov 15. doi: 10.1111/tbj.12966.
    PubMed     Text format    


  49. HLUBOCKY J, Bhavnagri S, Swinford A, Mitri C, et al
    Does the use of pretreatment MRI change the management of patients with newly diagnosed breast cancer?
    Breast J. 2017 Nov 5. doi: 10.1111/tbj.12946.
    PubMed     Text format     Abstract available


  50. SALERNO C, Vento AR, Giacchino M, Lissidini G, et al
    Intra-operative radiotherapy management for breast cancer treatment in patients with pseudoxanthoma elasticum: A case report.
    Breast J. 2017 Nov 5. doi: 10.1111/tbj.12944.
    PubMed     Text format     Abstract available


  51. SHAGISULTANOVA E, Mayordomo J, Elias AD
    Triple-negative breast cancer in the elderly.
    Breast J. 2017;23:627-629.
    PubMed     Text format    


    October 2017
  52. WHITWORTH PW, Cooper A
    Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12939.
    PubMed     Text format     Abstract available


  53. MERRILL RM
    Conditional relative survival among female breast cancer patients in the United States.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12933.
    PubMed     Text format    


  54. OBA T, Ono M, Iesato A, Hanamura T, et al
    Chylous leakage after axillary lymph node dissection in a patient with breast cancer.
    Breast J. 2017 Oct 24. doi: 10.1111/tbj.12934.
    PubMed     Text format    


  55. KHOURY A, Parihar V, O'steen L, Cherabuddi K, et al
    Pertuzumab and trastuzumab infusion related cytokine release syndrome in a chemotherapy naive patient with metastatic breast cancer.
    Breast J. 2017 Oct 13. doi: 10.1111/tbj.12943.
    PubMed     Text format     Abstract available


    September 2017
  56. BIGNON L, Fricker JP, Nogues C, Mouret-Fourme E, et al
    Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers.
    Breast J. 2017 Sep 19. doi: 10.1111/tbj.12887.
    PubMed     Text format     Abstract available


  57. OTA K, Rivera C, Martin M
    Specimen mammography distorts margin status in patients undergoing breast conserving surgery for early-stage breast cancer.
    Breast J. 2017 Sep 15. doi: 10.1111/tbj.12920.
    PubMed     Text format    


  58. TANG HKC, Lee DYH, Thompson I, Ingram JR, et al
    Delayed and localized pemphigus vulgaris after breast cancer radiotherapy.
    Breast J. 2017 Sep 11. doi: 10.1111/tbj.12910.
    PubMed     Text format     Abstract available


  59. YANG YL, Qian XL, Fu L
    Comparison of HER2 status of breast cancer between Chinese women in China and Chinese-American women in the US.
    Breast J. 2017 Sep 6. doi: 10.1111/tbj.12921.
    PubMed     Text format    


  60. LEE AY, Joe BN, Price ER
    The Predicament of the Probably Benign Breast MRI: Should We Rely on Intuition?
    Breast J. 2017;23:501-503.
    PubMed     Text format    


    August 2017
  61. MATHEW A, Achkar T, Abberbock S, Sandhu GS, et al
    Prevalence and determinants of end-of-life chemotherapy use in patients with metastatic breast cancer.
    Breast J. 2017 Aug 28. doi: 10.1111/tbj.12905.
    PubMed     Text format     Abstract available


  62. RODRIGUEZ CA, Martin T, Lozano R, Gomez A, et al
    Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer.
    Breast J. 2017 Aug 27. doi: 10.1111/tbj.12913.
    PubMed     Text format     Abstract available


  63. PALESH O, Scheiber C, Kesler S, Mustian K, et al
    Management of side effects during and post-treatment in breast cancer survivors.
    Breast J. 2017 Aug 27. doi: 10.1111/tbj.12862.
    PubMed     Text format     Abstract available


  64. OKINES A, Irfan T, Khabra K, Smith I, et al
    Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience.
    Breast J. 2017 Aug 22. doi: 10.1111/tbj.12906.
    PubMed     Text format     Abstract available


  65. MARCON M, Dedes K, Varga Z, Frauenfelder T, et al
    Influence of breast cancer opportunistic screening on aesthetic surgical outcome: A single-center retrospective study in Switzerland.
    Breast J. 2017 Aug 18. doi: 10.1111/tbj.12883.
    PubMed     Text format     Abstract available


    July 2017
  66. SUGRUE R, Carthy E, Kelly ME, Sweeney KJ, et al
    Science or popular media: What drives breast cancer online activity?
    Breast J. 2017 Jul 26. doi: 10.1111/tbj.12864.
    PubMed     Text format     Abstract available


  67. PAN K, Lin EM, Chlebowski RT
    Emerging combination endocrine therapies for advanced breast cancer.
    Breast J. 2017 Jul 26. doi: 10.1111/tbj.12876.
    PubMed     Text format    


  68. TANG HKC, Lee DYH, Thompson I, Ingram JR, et al
    Delayed and localized Sweets syndrome after breast cancer radiotherapy.
    Breast J. 2017 Jul 25. doi: 10.1111/tbj.12877.
    PubMed     Text format    


  69. LEHRER S, Green S, Rosenzweig KE
    Risk of malignant brain tumor as a second primary is significantly reduced after treatment of breast cancer.
    Breast J. 2017 Jul 20. doi: 10.1111/tbj.12880.
    PubMed     Text format    


  70. ALABDULKAREEM H, Pinchinat T, Khan S, Landers A, et al
    The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
    Breast J. 2017 Jul 14. doi: 10.1111/tbj.12853.
    PubMed     Text format     Abstract available


  71. DE LARA S, Parris TZ, Werner Ronnerman E, Helou K, et al
    GATA3 as a putative marker of breast cancer metastasis-A retrospective immunohistochemical study.
    Breast J. 2017 Jul 13. doi: 10.1111/tbj.12863.
    PubMed     Text format     Abstract available


  72. WOLLSCHLAGER D, Meng X, Wockel A, Janni W, et al
    Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients.
    Breast J. 2017 Jul 7. doi: 10.1111/tbj.12855.
    PubMed     Text format     Abstract available


    June 2017
  73. AKAY CL, Albarracin C, Torstenson T, Bassett R, et al
    Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer.
    Breast J. 2017 Jun 13. doi: 10.1111/tbj.12829.
    PubMed     Text format     Abstract available


  74. SANJARI MOGHADDAM A, Nazarzadeh M, Bidel Z, Karamatinia A, et al
    hOGG1 gene polymorphism and breast cancer risk: A systematic review and meta-analysis study.
    Breast J. 2017 Jun 13. doi: 10.1111/tbj.12842.
    PubMed     Text format     Abstract available


  75. SAKAMOTO I, Nakagomi H, Okimoto K, Inoue M, et al
    Unexpectedly low frequency of BRCA1/2 deleterious mutations in Japanese patients with breast cancer.
    Breast J. 2017 Jun 8. doi: 10.1111/tbj.12849.
    PubMed     Text format    


  76. GOMBERAWALLA A, Liou P, Martinez R, Rajpara R, et al
    Breast conservation for male breast cancer: Case report of intraoperative radiation.
    Breast J. 2017 Jun 8. doi: 10.1111/tbj.12847.
    PubMed     Text format     Abstract available


  77. FRANDSEN JE, Cannon G, Kokeny KE, Gaffney DK, et al
    Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review.
    Breast J. 2017 Jun 7. doi: 10.1111/tbj.12827.
    PubMed     Text format     Abstract available


    May 2017
  78. PAI T, Gupta S, Gurav M, Nag S, et al
    Evidence for the association of Epstein-Barr Virus in breast cancer in Indian patients using in-situ hybridization technique.
    Breast J. 2017 May 30. doi: 10.1111/tbj.12828.
    PubMed     Text format     Abstract available


  79. AGOPIAN A, Dubot C, Houzard S, Savignoni A, et al
    Pattern of relapse in low-risk breast cancer patients followed within a community care network.
    Breast J. 2017 May 27. doi: 10.1111/tbj.12821.
    PubMed     Text format     Abstract available


  80. FILLERON T, Pons E, Lusque A, Dalenc F, et al
    Impact of surgery on survival in stage IV breast cancer.
    Breast J. 2017 May 15. doi: 10.1111/tbj.12822.
    PubMed     Text format    


  81. KAPLAN HG, Malmgren JA, Atwood MK
    Triple-negative breast cancer in the elderly: Prognosis and treatment.
    Breast J. 2017 May 9. doi: 10.1111/tbj.12813.
    PubMed     Text format     Abstract available


  82. AL JOHANI B, Al Malik O, Anwar E, Tulbah A, et al
    Reply to "letter to the editor concerning the article-Impact of surgery on survival in stage IV breast cancer".
    Breast J. 2017 May 8. doi: 10.1111/tbj.12826.
    PubMed     Text format    


    April 2017
  83. LI M, Xu B, Shao Y, Liu H, et al
    Magnetic resonance imaging patterns of tumor regression in breast cancer patients after neo-adjuvant chemotherapy, and an analysis of the influencing factors.
    Breast J. 2017 Apr 10. doi: 10.1111/tbj.12811.
    PubMed     Text format     Abstract available


  84. ASSING MA, Patel BK, Karamsadkar N, Weinfurtner J, et al
    A comparison of the diagnostic accuracy of magnetic resonance imaging to axillary ultrasound in the detection of axillary nodal metastases in newly diagnosed breast cancer.
    Breast J. 2017 Apr 10. doi: 10.1111/tbj.12812.
    PubMed     Text format     Abstract available


    March 2017
  85. DARVISHI B, Farahmand L, Majidzadeh K
    Patterns of Cancer Stem Cell Negotiation with Breast Cancer Anti-angiogenic Therapy.
    Breast J. 2017 Mar 30. doi: 10.1111/tbj.12806.
    PubMed     Text format    


  86. OMARINI C, Filieri ME, Depenni R, Grizzi G, et al
    Osteonecrosis of the Jaw in a Breast Cancer Patient Treated with Everolimus and a Single Dose of Zoledronic Acid.
    Breast J. 2017 Mar 22. doi: 10.1111/tbj.12808.
    PubMed     Text format    


  87. ACKERMAN MG, Shapiro PA, Coe A, Trivedi MS, et al
    The Impact of Mental Illness on Uptake of Genetic Counseling for Hereditary Breast Cancer and Ovarian Cancer in a Multiethnic Cohort of Breast Cancer Patients.
    Breast J. 2017 Mar 21. doi: 10.1111/tbj.12791.
    PubMed     Text format     Abstract available


  88. GRIMM LJ, Zhang J, Baker JA, Soo MS, et al
    Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype.
    Breast J. 2017 Mar 13. doi: 10.1111/tbj.12799.
    PubMed     Text format     Abstract available


  89. KANTOR O, Pesce C, Liederbach E, Wang CH, et al
    Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy?
    Breast J. 2017 Mar 13. doi: 10.1111/tbj.12793.
    PubMed     Text format     Abstract available


  90. IQBAL J, Ginsburg O, Fischer HD, Austin PC, et al
    A Population-Based Cross-Sectional Study Comparing Breast Cancer Stage at Diagnosis between Immigrant and Canadian-Born Women in Ontario.
    Breast J. 2017 Mar 2. doi: 10.1111/tbj.12785.
    PubMed     Text format     Abstract available


  91. JINIH M, Relihan N, Corrigan MA, O'Reilly S, et al
    Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.
    Breast J. 2017 Mar 2. doi: 10.1111/tbj.12783.
    PubMed     Text format     Abstract available


  92. DE FELICE F, Ranalli T, Musio D, Lisi R, et al
    Relation between Hypofractionated Radiotherapy, Toxicity and Outcome in Early Breast Cancer.
    Breast J. 2017 Mar 2. doi: 10.1111/tbj.12792.
    PubMed     Text format     Abstract available


  93. ALTUNDAG K
    Higher Pretreatment and Aromatase Inhibitor Treatment-Related Cardiovascular Disease Risks in Postmenopausal Hormone Receptor-Positive Patients with Early Stage Breast Cancer.
    Breast J. 2017 Mar 1. doi: 10.1111/tbj.12782.
    PubMed     Text format    


  94. GROBMYER SR, Abraham J
    Putting Breast Cancer Patients First.
    Breast J. 2017;23:125-126.
    PubMed     Text format    


  95. GUTH AA, Chun Kim J, Schwartz S, Montes J, et al
    The Relationship of Race, Oncotype DX, and Ki67 in a Population Highly Screened For Breast Cancer.
    Breast J. 2017;23:177-181.
    PubMed     Text format     Abstract available


  96. OBA T, Maeno K, Ono M, Iesato A, et al
    A Case of Adenomyoepithelioma of the Breast Showing Strong Uptake of 18 F-Fluorodeoxyglucose on a Positron Emission Tomography.
    Breast J. 2017;23:220-224.
    PubMed     Text format     Abstract available


  97. ROSS DS, Giri DD, Akram MM, Catalano JP, et al
    Fibroepithelial Lesions in the Breast of Adolescent Females: A Clinicopathological Study of 54 Cases.
    Breast J. 2017;23:182-192.
    PubMed     Text format     Abstract available


  98. DUBENSKE LL, Schrager S, McDowell H, Wilke LG, et al
    Mammography Screening: Gaps in Patient's and Physician's Needs for Shared Decision-Making.
    Breast J. 2017;23:210-214.
    PubMed     Text format     Abstract available


    February 2017
  99. PETTIFORD J, Felts S, Wischkaemper E, Miller D, et al
    A Bio-Psychosocial Intervention Program for Improving Quality of Life in Breast Cancer Survivors - Final Outcome of a Prospective Randomized Trial.
    Breast J. 2017 Feb 24. doi: 10.1111/tbj.12786.
    PubMed     Text format     Abstract available


  100. CORDEIRO CN, Gemignani ML
    Breast Cancer in Pregnancy: Avoiding Fetal Harm When Maternal Treatment Is Necessary.
    Breast J. 2017 Feb 13. doi: 10.1111/tbj.12780.
    PubMed     Text format     Abstract available


    January 2017
  101. SEOL YM, Kim DY, Kim HJ, Choi YJ, et al
    Reversible Posterior Leukoencephalopathy Syndrome after Eribulin Mesylate Chemotherapy for Breast Cancer.
    Breast J. 2017 Jan 31. doi: 10.1111/tbj.12776.
    PubMed     Text format    


  102. DUMAIS V, Lumingu J, Bedard M, Paquet L, et al
    Prevalence of Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes in Canadian Women at High Risk for Breast Cancer.
    Breast J. 2017 Jan 25. doi: 10.1111/tbj.12772.
    PubMed     Text format    


  103. DALDOUL A, Ben Ahmed K, Tlili G, Krir MW, et al
    Female Sexuality in Premenopausal Patients with Breast Cancer on Endocrine Therapy.
    Breast J. 2017 Jan 24. doi: 10.1111/tbj.12778.
    PubMed     Text format    


  104. DOWNS B, Xiao F, Kim YC, Chen PX, et al
    Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.
    Breast J. 2017 Jan 24. doi: 10.1111/tbj.12777.
    PubMed     Text format    


  105. ACCURSO A, Rocco N, Della Corte GA, Accardo G, et al
    Breast Cancer Surgery Under General Anesthesia: Is it Really Worth it?
    Breast J. 2017 Jan 24. doi: 10.1111/tbj.12775.
    PubMed     Text format    


  106. TAN C, Caragata R, Bennett I
    Is Sentinel Node Biopsy of the Internal Mammary Lymph Nodes Relevant in the Management of Breast Cancer?
    Breast J. 2017 Jan 24. doi: 10.1111/tbj.12754.
    PubMed     Text format     Abstract available


  107. ALARID-ESCUDERO F, Blaes AH, Kuntz KM
    Trade-offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients: Do Competing Risks Matter?
    Breast J. 2017 Jan 24. doi: 10.1111/tbj.12757.
    PubMed     Text format     Abstract available


  108. MANSFIELD SA, Abdel-Rasoul M, Terando AM, Agnese DM, et al
    Timing of Breast Cancer Surgery-How Much Does It Matter?
    Breast J. 2017 Jan 24. doi: 10.1111/tbj.12758.
    PubMed     Text format     Abstract available


  109. FELTS JL, Zhu J, Han B, Smith SJ, et al
    An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer.
    Breast J. 2017 Jan 18. doi: 10.1111/tbj.12751.
    PubMed     Text format     Abstract available


  110. WANG C, Zhu H, Zhou Y, Mao F, et al
    Prognostic Value of PD-L1 in Breast Cancer: A Meta-Analysis.
    Breast J. 2017 Jan 12. doi: 10.1111/tbj.12753.
    PubMed     Text format     Abstract available


  111. NAVARRO VILAR L, Alandete German SP, Medina Garcia R, Blanc Garcia E, et al
    MR Imaging Findings in Molecular Subtypes of Breast Cancer According to BIRADS System.
    Breast J. 2017 Jan 9. doi: 10.1111/tbj.12756.
    PubMed     Text format     Abstract available


  112. LIU S, Khalkhali I
    Probably Benign Findings: Probably the Emperor with No Clothes.
    Breast J. 2017;23:8-9.
    PubMed     Text format    


    December 2016
  113. MERESSE M, Bouhnik AD, Bendiane MK, Retornaz F, et al
    Chemotherapy in Old Women with Breast Cancer: Is Age Still a Predictor for Under Treatment?
    Breast J. 2016 Dec 31. doi: 10.1111/tbj.12726.
    PubMed     Text format     Abstract available


  114. MORRONE D, Saguatti G, Benelli E, Fedato C, et al
    Post-Treatment Follow-Up of Screen-Detected Breast Cancer Patients: A National Survey from Italy.
    Breast J. 2016 Dec 26. doi: 10.1111/tbj.12745.
    PubMed     Text format    


  115. GROVER S, Nurkic S, Diener-West M, Showalter SL, et al
    Survival after Breast-Conserving Surgery with Whole Breast or Partial Breast Irradiation in Women with Early Stage Breast Cancer: A SEER Data-base Analysis.
    Breast J. 2016 Dec 18. doi: 10.1111/tbj.12729.
    PubMed     Text format     Abstract available


  116. MARMOR S, Portschy PR, Burke EE, Virnig BA, et al
    Prognostic Factors for Metachronous Contralateral Breast Cancer: Implications for Management of the Contralateral Breast.
    Breast J. 2016 Dec 18. doi: 10.1111/tbj.12732.
    PubMed     Text format     Abstract available


  117. MARSHALL EM, Bertaut A, Desmoulins I, Darut-Jouve A, et al
    Prognostic Factors of Survival among Women with Metastatic Breast Cancer and Impact of Primary or Secondary Nature of Disease on Survival: A French Population-Based Study.
    Breast J. 2016 Dec 9. doi: 10.1111/tbj.12717.
    PubMed     Text format     Abstract available


  118. BOZKURT M, Palmer LJ, Guo Y
    Effectiveness of Decongestive Lymphatic Therapy in Patients with Lymphedema Resulting from Breast Cancer Treatment Regardless of Previous Lymphedema Treatment.
    Breast J. 2016 Dec 7. doi: 10.1111/tbj.12710.
    PubMed     Text format     Abstract available


  119. ARFI A, Clavier A, Honart JF, Ammari S, et al
    Blue Lymphangitis of the Breast after Breast Cancer: Case Report.
    Breast J. 2016 Dec 3. doi: 10.1111/tbj.12738.
    PubMed     Text format     Abstract available


    November 2016
  120. DE OLIVEIRA I JUNIOR, Viana CR, Sabino SM, Kerr LM, et al
    Xanthogranulomatous Mastitis Mimicking Locally Advanced Breast Cancer.
    Breast J. 2016 Nov 30. doi: 10.1111/tbj.12719.
    PubMed     Text format    


  121. ANAMPA J, Sparano JA
    Tailoring Adjuvant Therapy for Breast Cancer in the Elderly: Room for Improvement.
    Breast J. 2016 Nov 30. doi: 10.1111/tbj.12730.
    PubMed     Text format    


  122. KOSEHAN D, Dener C, Akin K, Bozkurt A, et al
    The Value of Preoperative Lesion Dedicated Ultrasound of Breast Cancer before Conserving Surgery for Optimizing Margins.
    Breast J. 2016 Nov 3. doi: 10.1111/tbj.12711.
    PubMed     Text format     Abstract available


  123. WANG WS, Hardesty L, Borgstede J, Takahashi J, et al
    Breast Cancers Found with Digital Breast Tomosynthesis: A Comparison of Pathology and Histologic Grade.
    Breast J. 2016;22:651-656.
    PubMed     Text format     Abstract available


  124. EUHUS DM
    Choosing Bilateral Mastectomy.
    Breast J. 2016;22:605-606.
    PubMed     Text format    


  125. MA XL, Kang L, Li BJ, He CN, et al
    Invasive Ductal Carcinoma Displayed "Basal-Like" Feature Arising within a Breast Fibroadenoma.
    Breast J. 2016;22:695-696.
    PubMed     Text format    


    October 2016
  126. CHURILLA TM, Egleston B, Bleicher R, Dong Y, et al
    Disparities in the Local Management of Breast Cancer in the US according to Health Insurance Status.
    Breast J. 2016 Oct 31. doi: 10.1111/tbj.12705.
    PubMed     Text format     Abstract available


  127. SOTO S, Toesca A, Hamza A, Della Corte GA, et al
    Supernumerary Axillary Breast Cancer.
    Breast J. 2016 Oct 31. doi: 10.1111/tbj.12724.
    PubMed     Text format    


  128. ALTUNDAG K
    Primary Surgery After or Before Systemic Treatment May Affect the Survival Results in Stage IV Breast Cancer Patients.
    Breast J. 2016 Oct 31. doi: 10.1111/tbj.12700.
    PubMed     Text format    


  129. AL JOHANI B, Al Malik O, Anwar E, Tulbah A, et al
    Reply to "Letter to the Editor Concerning the Article-Impact of Surgery on Survival in Stage IV Breast Cancer".
    Breast J. 2016 Oct 31. doi: 10.1111/tbj.12701.
    PubMed     Text format    


  130. JAVID SH, Lawrence SO, Lavallee DC
    Prioritizing Patient-Reported Outcomes in Breast Cancer Surgery Quality Improvement.
    Breast J. 2016 Oct 25. doi: 10.1111/tbj.12707.
    PubMed     Text format     Abstract available


  131. GALLICCHIO L, Calhoun C, Riseberg D, Helzlsouer K, et al
    Cardiovascular Health among Black and White Breast Cancer Patients Initiating Aromatase Inhibitor Therapy.
    Breast J. 2016 Oct 25. doi: 10.1111/tbj.12709.
    PubMed     Text format     Abstract available


  132. CACCIA D, Scaffidi M, Andreis C, Luziatelli S, et al
    Quality of Life after Invasive or Breast-Conserving Surgery for Breast Cancer.
    Breast J. 2016 Oct 25. doi: 10.1111/tbj.12723.
    PubMed     Text format    


    September 2016
  133. GLOWACKA I, Nowikiewicz T, Hagner W, Nowacka K, et al
    Sagittal Plane Postural Changes in Female Patients with Breast Cancer after Different Surgical Techniques.
    Breast J. 2016 Sep 26. doi: 10.1111/tbj.12697.
    PubMed     Text format    


  134. VANDERBEEK L, Francescutti V, Farrokhyar F, Lovrics P, et al
    Primary Breast Cancer Tumor and Patient Characteristics as Predictors of Adjuvant Radiation Therapy.
    Breast J. 2016 Sep 26. doi: 10.1111/tbj.12684.
    PubMed     Text format     Abstract available


  135. BRUFSKY AM, Ormerod C, Bell Dickson R, Citron ML, et al
    Understanding the Needs of Patients with Metastatic Breast Cancer: Results of the Make Your Dialogue Count Survey.
    Breast J. 2016 Sep 13. doi: 10.1111/tbj.12675.
    PubMed     Text format     Abstract available


    August 2016
  136. ALJOHANI B, AlMalik O, Anwar E, Tulbah A, et al
    Impact of Surgery on Survival in Stage IV Breast Cancer.
    Breast J. 2016 Aug 26. doi: 10.1111/tbj.12662.
    PubMed     Text format     Abstract available


  137. KOWALCZYK L, Singer CF, Staudigl C, Weber M, et al
    Adverse Mucocutaneous Reaction to Pertuzumab in a Patient with HER2-Positive Metastatic Breast Cancer.
    Breast J. 2016 Aug 26. doi: 10.1111/tbj.12676.
    PubMed     Text format    


  138. GOODRICH ME, Weiss J, Onega T, Balch SL, et al
    The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women.
    Breast J. 2016 Aug 23. doi: 10.1111/tbj.12651.
    PubMed     Text format     Abstract available


  139. MENEN RS, Hunt KK
    Considerations for the Treatment of Young Patients with Breast Cancer.
    Breast J. 2016 Aug 19. doi: 10.1111/tbj.12644.
    PubMed     Text format     Abstract available


  140. AGRANAT S, Baris H, Kedar I, Shochat M, et al
    Earlier Age of Breast Cancer Onset in Israeli BRCA Carriers-Is it a Real Phenomenon?
    Breast J. 2016 Aug 17. doi: 10.1111/tbj.12653.
    PubMed     Text format     Abstract available


  141. ARDALAN A, Bungum T
    Gestational Age and the Risk of Maternal Breast Cancer: A Population-Based Case-Control Study.
    Breast J. 2016 Aug 10. doi: 10.1111/tbj.12646.
    PubMed     Text format     Abstract available


  142. YAN W, Zhang Y, Zhao E, Zhang S, et al
    Association between the MTHFR C677T Polymorphism and Breast Cancer Risk: A Meta-Analysis of 23 Case-Control Studies.
    Breast J. 2016 Aug 10. doi: 10.1111/tbj.12639.
    PubMed     Text format    


  143. IQBAL B, Masood A, Lone MM, Lone AR, et al
    Polymorphism of Metastasis Suppressor Genes MKK4 and NME1 in Kashmiri Patients with Breast Cancer.
    Breast J. 2016 Aug 10. doi: 10.1111/tbj.12668.
    PubMed     Text format     Abstract available


  144. SHAH C, Vicini FA, Arthur D
    Bioimpedance Spectroscopy for Breast Cancer Related Lymphedema Assessment: Clinical Practice Guidelines.
    Breast J. 2016 Aug 4. doi: 10.1111/tbj.12647.
    PubMed     Text format     Abstract available


    July 2016
  145. AGRAWAL S, Jayant K
    Breast Cancer with Metastasis to the Nasopharynx and Paranasal Sinuses.
    Breast J. 2016;22:476-7.
    PubMed     Text format    


    June 2016
  146. MOLTO GARCIA R, Salmeron-Gonzalez E, Argudo Pechuan MD, Perez-Garcia A, et al
    Breast Cancer Recurrence in an Axillary Limphadenectomized Patient Who Underwent Lymph Node Transfer in the Axillar Region: What to Do with the Axilla?
    Breast J. 2016 Jun 27. doi: 10.1111/tbj.12640.
    PubMed     Text format    


  147. LEONE JP
    Gemcitabine Induced Cutaneous Collagenous Vasculopathy in a Breast Cancer Patient.
    Breast J. 2016 Jun 27. doi: 10.1111/tbj.12638.
    PubMed     Text format    


  148. CHATZIRALLI I, Sergentanis T, Zagouri F, Chrysikos D, et al
    Ocular Surface Disease in Breast Cancer Patients Using Aromatase Inhibitors.
    Breast J. 2016 Jun 14. doi: 10.1111/tbj.12633.
    PubMed     Text format     Abstract available


  149. LEHRER S, Green S, Rosenzweig KE
    Affluence and Breast Cancer.
    Breast J. 2016 Jun 14. doi: 10.1111/tbj.12630.
    PubMed     Text format     Abstract available


  150. NAYAK L, Miyake KK, Leung JW, Price ER, et al
    Impact of Breast Density Legislation on Breast Cancer Risk Assessment and Supplemental Screening: A Survey of 110 Radiology Facilities.
    Breast J. 2016 Jun 14. doi: 10.1111/tbj.12624.
    PubMed     Text format     Abstract available


  151. KHALIFA J, Duprez-Paumier R, Filleron T, Lacroix Triki M, et al
    Outcome of pN0 Triple-Negative Breast Cancer with or without Lymph Node Irradiation: A Single Institution Experience.
    Breast J. 2016 Jun 4. doi: 10.1111/tbj.12626.
    PubMed     Text format     Abstract available


    May 2016
  152. TALIB Z, Shukurbekova I, Sadonshoeva G, Alibekov A, et al
    A Community-Oriented Approach to Breast Cancer in a Low-Resource Setting: Improving Awareness, Early Detection and Treatment of Breast Cancer in Tajikistan.
    Breast J. 2016;22:330-4.
    PubMed     Text format     Abstract available


  153. HO AM, Kalantari BN
    PET/MRI: A New Frontier in Breast Cancer Imaging.
    Breast J. 2016;22:261-3.
    PubMed     Text format    


    March 2016
  154. DERSHAW DD
    Preoperative MRI.
    Breast J. 2016;22:141-2.
    PubMed     Text format    


    January 2016
  155. JACOBS C, Clemons M, Addison C, Robertson S, et al
    Issues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the Breast.
    Breast J. 2016;22:45-53.
    PubMed     Text format     Abstract available


  156. WEI CH, Scott AM, Price AN, Miller HC, et al
    Psychosocial and Sexual Well-Being Following Nipple-Sparing Mastectomy and Reconstruction.
    Breast J. 2016;22:10-7.
    PubMed     Text format     Abstract available


  157. WOMMACK CC, Spiegel AJ
    Beyond Quantitative Measurement of Breast Reconstruction Outcomes: Evaluation of Nipple-Sparing Mastectomy and the Breast-Q.
    Breast J. 2016;22:7-9.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: